arrow
M

Mark R. Davis

pathwest laboratory medicine
H指数:52
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Congenital Titinopathy: Comprehensive Characterization of the Most Severe End of the Disease Spectrum
2025-01-240
OAAI
A CCG expansion in ABCD3 causes oculopharyngodistal myopathy in individuals of European ancestry (vol 15, 6327, 2024)
2024-10-170
OAAI
A CCG expansion in ABCD3 causes oculopharyngodistal myopathy in individuals of European ancestry
2024-07-272
OAAI
Pathogenic TNNI1 variants disrupt sarcomere contractility resulting in hypo- and hypercontractile muscle disease
2024-04-032
OA
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone

基因组和RNA测序仅通过外显子组测序就可以促进神经肌肉诊断从34% 中62%

2024-03-272
OA
Digenic inheritance involving a muscle-specific protein kinase and the giant titin protein causes a skeletal muscle myopathy
2024-03-017
OAAI
RFC1 in an Australasian neurological disease cohort: extending the genetic heterogeneity and implications for diagnostics

澳大利亚神经系统疾病队列中的RFC1: 扩展遗传异质性及其对诊断的意义

2023-07-256
OAAI
Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation

Shariant平台: 支持澳大利亚临床基因检测实验室之间的证据共享,以支持变异解释

2022-11-0113
OAAI
The Australian Reproductive Genetic Carrier Screening Project (Mackenzie's Mission): Design and Implementation
2022-10-2832
OAAI